Taken together, these data indicate that silencing LARP7 in noninvasive breast cancer cells shifts the P-TEFb equilibrium from the inhibitory 7SK snRNP to the active SEC, leading to increased P-TEFb activity and expression of EMT-related transcription factors. Here, LARP7 is linked to breast carcinoma.